AstraZeneca Posted August 7, 2026

Global Development Medical Director

Mölndal, Sweden Full time
Clinical Development Director

AstraZeneca is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

Job Description As a Study Clinical Lead, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives. The successful Study Clinical Lead in Late Phase CVRM (Cardiovascular, Renal, and Metabolic diseases) will be responsible for the design, conduct, monitoring, data interpretation and reporting of individual clinical trials ensuring that the clinical data collected within the study will allow determination of the benefits and risks of the compound, as well as will allow for the intended label indication and price in markets globally. The individual will operate according to the highest ethical standards in compliance with internal SOPs, local regulations, laws, Good Clinical Practice, and regulatory requirements.

Responsibilities

Provides strategic medical and scientific knowledge (Cardiovascular, Renal, Metabolic, and/or Hepatic Diseases) and supports the design, initiation, execution, completion, and interpretation of a clinical study

Is accountable for study designs

Is accountable to deliver medical information, answers, and clarifications to Regulators, Ethic Committees, Marketing Companies, Investigators/Sites

Trial conduct and hands-on delivery accountabilities

Is accountable to the Global Clinical Head (GCH) or delegate for the medical aspects and designs of studies

Is responsible for driving decisions within Study Team (ST) remits together with other ST members and for solving medical issues in the study team

Is accountable for the medical and ethical components of studies including patient safety on a study level in compliance with GCP

Is accountable for delivery of the clinical components of all relevant study documents (e.g Protocol, Amendments, Statistical Analysis Plan, Informed Consent Form, Case Report Forms, and Safety and Risk-Based Monitoring Plans)

Is accountable for ensuring that safety surveillance on a study level including the process for Adverse Events (AE)/ Serious AE reporting, the querying of missing/unclear data, the review of blinded safety data, and the escalation to the GCH/Global Safety Physician when needed.

Is medically accountable for international investigator meetings, and supports Marketing Companies (MC) in national activities

Approves (with the GCH) the Clinical Study Report; including preparation and production thereof (Introduction, Results, Discussion).

Is accountable for ST induction and education of new members in the study team, as well as others involved in the study

Collaborates seamlessly and efficiently with global colleagues at other R&D sites

May be accountable to GCH (or delegate) and leadership for identifying risks and proposing mitigation strategies to deliver successful Phase II, III, IV or Life Cycle Management studies

Scientific medical analytical accountabilities

Stays updated on relevant scientific literature

Delivers analyses of clinical data in a balanced, statistically sound fashion, to drive interpretations and further idea generation

Serves as a source of medical expertise for the Product Team, in analyses and interpretation of medical data

Messaging and external impact accountabilities

Maintains a high degree of understanding and awareness on new and emerging medical development, globally.

Works with international colleagues and with external Alliance partners on development initiatives and regulatory issues

Applies strategic intent of AstraZeneca when working with Alliance partners, Regulatory Authorities, payers, opinion leaders, prescribers and consumers of AstraZeneca products

Able to provide guidance for investigator-initiated trials in cooperation with regional marketing companies

Minimum Requirements  

Graduate of a recognized school of medicine with an M.B.B.S., M.D. degree or equivalent, and/or a graduate of a scientific doctorate (e.g. PhD or PharmD) or equivalent in a scientific discipline or Pharmaceutical Medicine

Proven teamwork and collaboration skills

Fluent in oral and written English

Good presentation skills and effective communication

A clear demonstration of:

Leadership qualities, with particular focus on collaborative working skills, trust and openness, irrespective of cultural setting

AstraZeneca values and behaviors

Agile responsiveness to scientific data

Credibility in scientific and commercial environments

Desired Experience: 

Good general medical knowledge preferably in endocrinology, nephrology, or MASH

Experience of clinical research and clinical expertise in one of our core therapy areas are valued assets

3+ years clinical research expertise in relevant therapy area in study design, protocol development, monitoring and implementing clinical trials, interpreting and reporting trial results

Good knowledge of biostatistics, global regulatory environment and pharmacovigilance

An understanding of pharmaceutical industry R&D, particularly of major clinical milestones and of the factors which influence drug development

An understanding of the interplay between clinical, commercial objectives, drug safety and regulatory requirements

Why AstraZeneca?Here, we need leadership at every level - leaders who not only have expertise, but also the ability to build a case, engage multiple partners, and communicate effectively with different audiences. Early clinical development is at the forefront of discovery of new medicines for patients with high unmet need. With that kind of remit comes great responsibility. Your curiosity and passion for personal development combined with support from colleagues, mentors and leaders, will ensure you maximize your skills, abilities and contribution. We offer a competitive salary and excellent benefits

Date Posted

07-Aug-2026

Closing Date

17-Aug-2026

Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

Job details

Seniority
Director
Function
Clinical Development
Therapeutic area
Not listed
Location
Mölndal, Sweden
Employment type
Full time

How this role compares

Computed from every other active Clinical Development role in our database, not just this employer's listings.

We currently track 184 comparable Director Clinical Development roles across 28 biopharma companies.

184Comparable roles tracked
157Currently active
28Companies hiring similar roles
16Countries represented

Salary context

90 of 184 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject Not listed on this posting
Lowest disclosed · Clinical Research Director (P4-P5) · Lilly $101,379/yr – $181,067/yr
Peer group range $141,223 – $392,100 (median $272,025)

Where these roles are based

Top locations among the 184 comparable roles

United States135
Spain10
United Kingdom9
India5
Poland4
China4

+ 10 more countries

Seniority mix

184 of 184 peers have a known seniority level

Director140
Principal23
Senior Director21

Therapeutic area mix

78 of 184 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology34
Immunology18
Cardiovascular / CVRM7
Neuroscience7
Respiratory6
Dermatology & Aesthetics2
Ophthalmology2
Rare Disease1
Vaccines & Infectious Disease1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

45%similar
AstraZeneca Gaithersburg, Maryland, United States of America Director
Same function Same seniority
45%similar
AstraZeneca Şişli, İstanbul, Türkiye Director
Same function Same seniority
45%similar
AstraZeneca Barcelona, Spain Director
Same function Same seniority
45%similar
AstraZeneca Director
Same function Same seniority

Open in 2 locations

Barcelona, SpainGaithersburg, United States
45%similar
AstraZeneca Boston, Massachusetts, United States of America Director
Same function Same seniority
45%similar
AstraZeneca Gaithersburg, Maryland, United States of America Director
Same function Same seniority

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

45%
Global Development Medical Director, Late Respiratory and Immunology Clinical Development
AstraZeneca · Gaithersburg, Maryland, United States of America · Director
Function Therapeutic area Seniority Country
45%
Global Development Medical Director, Hematology Oncology
AstraZeneca · Barcelona, Spain · Director
Function Therapeutic area Seniority Country
45%
Senior Medical Director, Kidney Disease, Early Clinical Development CVRM
AstraZeneca · Gaithersburg, Maryland, United States of America · Director
Function Therapeutic area Seniority Country
45%
Global Development Medical Director
AstraZeneca · Boston, Massachusetts, United States of America · Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.